OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Indexing: DOAJ-Directory of Open Access Journals.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 7.5 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period).
Submission Deadline: June 30, 2020 (Open) Submit Now
Department of Neurology, Skånes universitetssjukhus, Lund, Sweden
Research Interests: Translational Neurology; Movement Disorders; Parkinson´s Disease; Regeneration; Neurology; Vascular Biology in Neurodeneneration; Pericytes; Growth Factors
About This Topic
In a time when the world’s population is aging, the health burden of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease is constantly increasing. To manage the larger number of patients and the connected health costs, brain research has to direct a sharp focus towards developing neuroregenerative or neuroprotective treatments. Today, all clinically available therapies for neuroregenerative disorders, with no exception, are symptomatic treatments. We urgently need novel treatments that bring a paradigm shift in order to stop disease progression and to stimulate regeneration.
Neuroregeneration refers to the recovery, repair or regrowth of damaged structures of the endogenous nervous tissue and may also include neuroprotection which aims at slowing the course of neurodegeneration. Mechanisms are multifold and subject of interest for many researcher all over the world.
This special issue addresses different topics related to the neuroregeneration in central nervous system (CNS), including potential biomarkers for regeneration. Original research reports, review articles, communications, and perspectives are welcome in all areas pertinent to this topic. All accepted papers will be published free of charge.
Neuroregeneration, Neurogenesis; Neuroplasticity; Neurorestoration; Neuroprotection
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.